Similar articles

• A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine.

  Peveler R, Kendrick T, Buxton M, Longworth L, Baldwin D, Moore M, Chatwin J, Goddard J, Thornett A, Smith H, Campbell M, Thompson C. Peveler R, et al. Health Technol Assess. 2005 May;9(16):1-134, iii. doi: 10.3310/hta9160. Health Technol Assess. 2005. PMID: 15876362 Clinical Trial.
• Cost-effectiveness and cost-utility of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine: randomised controlled trial.

  Kendrick T, Peveler R, Longworth L, Baldwin D, Moore M, Chatwin J, Thornett A, Goddard J, Campbell M, Smith H, Buxton M, Thompson C. Kendrick T, et al. Br J Psychiatry. 2006 Apr;188:337-45. doi: 10.1192/bjp.188.4.337. Br J Psychiatry. 2006. PMID: 16582060 Clinical Trial.
• [Selective serotonin uptake in depression. Same therapeutic effect as tricyclic agents but better side effect profile and lower toxicity?].

  Mårtensson B. Mårtensson B. Lakartidningen. 1992 Dec 9;89(50):4395-9. Lakartidningen. 1992. PMID: 1469979 Swedish. No abstract available.
• [Antidepressants in depression of the elderly].

  Gulmann NC. Gulmann NC. Ugeskr Laeger. 2007 Aug 13;169(33):2625-7. Ugeskr Laeger. 2007. PMID: 17725909 Review. Danish. No abstract available.
• Antidepressants in the treatment of migraine headache.

  Punay NC, Couch JR. Punay NC, et al. Curr Pain Headache Rep. 2003 Feb;7(1):51-4. doi: 10.1007/s11916-003-0010-8. Curr Pain Headache Rep. 2003. PMID: 12525271 Review.